Effectiveness of Ticagrelor Compared to Clopidogrel in Reducing the Risk of Major Adverse Cardiovascular Events in Patients with Coronary Heart Disease After Percutaneous Coronary Intervention

被引：0
|
作者：
Nur'amin, Hendra Wana [1 ]
Dwiprahasto, Iwan [2 ]
Kristin, Erna [2 ]
机构：
[1] Lambung Mangkurat Univ, Pharmacol & Therapy, Banjarmasin, South Kalimanta, Indonesia
[2] Gadjah Mada Univ, Pharmacol & Therapy, Yogyakarta, Indonesia
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
975
引用
收藏
页码：567 / 567
页数：1
相关论文
共 50 条
  • [21] Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease
    Orme, Rachel C.
    Parker, William A. E.
    Thomas, Mark R.
    Judge, Heather M.
    Baster, Kathleen
    Sumaya, Wael
    Morgan, Kenneth P.
    McMellon, Hannah C.
    Richardson, James D.
    Grech, Ever D.
    Wheeldon, Nigel M.
    Hall, Ian R.
    Iqbal, Javaid
    Barmby, David
    Gunn, Julian P.
    Storey, Robert F.
    CIRCULATION, 2018, 138 (13) : 1290 - 1300
  • [22] Predictors of 30-day major adverse cardiovascular events after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel
    Mrdovic, I.
    Savic, L.
    Asanin, M.
    Perunicic, J.
    Lasica, R.
    Marinkovic, J.
    Vasiljevic, Z.
    Ostojic, M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 40 - 40
  • [23] Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
    Cai, Anping
    Dillon, Chrisly
    Hillegass, William B.
    Beasley, Mark
    Brott, Brigitta C.
    Bittner, Vera A.
    Perry, Gilbert J.
    Halade, Ganesh V.
    Prabhu, Sumanth D.
    Limdi, Nita A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (22):
  • [24] The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention
    Giantini, Astuti
    Timan, Ina S.
    Dharma, Rahajuningsih
    Sukmawan, Renan
    Setiabudy, Rianto
    Alwi, Idrus
    Harahap, Alida R.
    Listiyaningsih, Erlin
    Partakusuma, Lia G.
    Tansir, Arif R.
    Sahar, Windy
    Hidayat, Rakhmad
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 9
  • [25] Clopidogrel use in coronary heart disease and percutaneous coronary intervention
    Atiemo, Andrew D.
    Williarns, Marlene S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (04) : 689 - 700
  • [26] Prediction models for major adverse cardiovascular events after percutaneous coronary intervention: a systematic review
    Deng, Wenqi
    Wang, Dayang
    Wan, Yandi
    Lai, Sijia
    Ding, Yukun
    Wang, Xian
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 10
  • [27] Predicting major adverse cardiac events after percutaneous coronary intervention: The Texas Heart Institute risk score
    Madan, Pankaj
    Elayda, MacArthur A.
    Lee, Vei-Vei
    Wilson, James M.
    AMERICAN HEART JOURNAL, 2008, 155 (06) : 1068 - 1074
  • [28] Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
    Li, Jianan
    Qiu, Hong
    Yan, Lirong
    Guo, Tingting
    Wang, Yong
    Li, Yang
    Zheng, Jianfeng
    Tang, Yida
    Xu, Bo
    Qiao, Shubin
    Yang, Yuejin
    Gao, Runlin
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (08) : 873 - 882
  • [29] Stent Thrombosis With Ticagrelor Versus Clopidogrel After Percutaneous Coronary Intervention and Ticagrelor or Clopidogrel in Patients With Acute Coronary Syndromes in a Real World Setting
    Fallesen, Christian O.
    Thayssen, Per
    Pedersen, Knud Erik
    Junker, Anders
    Hansen, Knud N.
    Hansen, Henrik S.
    Veien, Karsten T.
    Jensen, Lisette Okkels
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B145 - B145
  • [30] Value of Echocardiographic Evaluation of Myocardial Performance Index in Predicting Major Adverse Cardiovascular Events Within 1 Year after Percutaneous Coronary Intervention in Patients with Coronary Heart Disease
    Yang, Junfang
    You, Fangwei
    Wang, Jinglei
    HEART SURGERY FORUM, 2024, 27 (07): : E750 - E756
12345